Application 204623
- Type
- NDA
- Sponsor
- HORIZON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PENNSAID | DICLOFENAC SODIUM | SOLUTION;TOPICAL | 2% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204623-001 | PENNSAID | DICLOFENAC SODIUM | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / TOPICAL | RLD | 2014-01-16 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204623-001 | 8563613 | 2027-10-17 | U-1488 | Drug product | 2014-02-25 |
| N204623-001 | 8871809 | 2027-10-17 | U-1614 | 2014-11-18 | |
| N204623-001 | 9066913 | 2027-10-17 | U-1488 | Drug product | 2015-06-30 |
| N204623-001 | 9101591 | 2027-10-17 | U-1488 | Drug product | 2015-08-11 |
| N204623-001 | 9132110 | 2027-10-17 | U-1488 | 2015-09-16 | |
| N204623-001 | 9168304 | 2027-10-17 | Drug product | 2015-10-27 | |
| N204623-001 | 9168305 | 2027-10-17 | U-1488 | 2015-10-27 | |
| N204623-001 | 9220784 | 2027-10-17 | U-1488 | 2016-01-28 | |
| N204623-001 | 9339551 | 2027-10-17 | U-1488 | 2016-06-16 | |
| N204623-001 | 9339552 | 2027-10-17 | U-1488 | Drug product | 2016-06-16 |
| N204623-001 | 9539335 | 2027-10-17 | U-1614 | 2016-02-06 | |
| N204623-001 | 8252838 | 2028-04-21 | U-1489 | Drug product | 2014-02-25 |
| N204623-001 | 8217078 | 2029-07-10 | U-1477 | 2014-02-25 | |
| N204623-001 | 8618164 | 2029-07-10 | U-1477 | 2014-02-25 | |
| N204623-001 | 8741956 | 2029-07-10 | U-1435 | 2014-06-05 | |
| N204623-001 | 9370501 | 2029-07-10 | U-1614 | 2016-07-19 | |
| N204623-001 | 9375412 | 2029-07-10 | U-1614 | 2016-07-26 | |
| N204623-001 | 9415029 | 2029-07-10 | U-1614 | 2016-09-13 | |
| N204623-001 | 8546450 | 2030-08-09 | U-1435 | 2014-02-25 | |
| N204623-001 | 8546450 | 2030-08-09 | U-1436 | 2014-02-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N204623-001 | PENNSAID | 2% | SOLUTION / TOPICAL | AB | RLD, RS | 2014-01-16 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N204623-001 | PENNSAID | 2% | SOLUTION / TOPICAL | AB | RLD, RS | 2014-01-16 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N204623-001 | PENNSAID | 2% | SOLUTION / TOPICAL | AB | RLD, RS | 2014-01-16 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N204623-001 | PENNSAID | 2% | SOLUTION / TOPICAL | AB | RLD, RS | 2014-01-16 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N204623-001 | PENNSAID | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / TOPICAL | RLD | 2014-01-16 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204623-001 | AB | 1 | 5c6f7cd8ea54… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N204623-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N204623-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N204623-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N204623-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N204623-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N204623-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N204623-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N204623-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N204623-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N204623-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N204623-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N204623-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N204623-001 | AB | 1 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8563613 | 2027-10-17 | U-1488 | Drug product | 2014-02-25 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8871809 | 2027-10-17 | U-1614 | 2014-11-18 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9066913 | 2027-10-17 | U-1488 | Drug product | 2015-06-30 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9101591 | 2027-10-17 | U-1488 | Drug product | 2015-08-11 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9132110 | 2027-10-17 | U-1488 | 2015-09-16 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9168304 | 2027-10-17 | Drug product | 2015-10-27 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9168305 | 2027-10-17 | U-1488 | 2015-10-27 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9220784 | 2027-10-17 | U-1488 | 2016-01-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9339551 | 2027-10-17 | U-1488 | 2016-06-16 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9339552 | 2027-10-17 | U-1488 | Drug product | 2016-06-16 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9539335 | 2027-10-17 | U-1614 | 2016-02-06 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8252838 | 2028-04-21 | U-1489 | Drug product | 2014-02-25 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8217078 | 2029-07-10 | U-1477 | 2014-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8618164 | 2029-07-10 | U-1477 | 2014-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8741956 | 2029-07-10 | U-1435 | 2014-06-05 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9370501 | 2029-07-10 | U-1614 | 2016-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9375412 | 2029-07-10 | U-1614 | 2016-07-26 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 9415029 | 2029-07-10 | U-1614 | 2016-09-13 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8546450 | 2030-08-09 | U-1435 | 2014-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204623-001 | 8546450 | 2030-08-09 | U-1436 | 2014-02-25 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8563613 | 2027-10-17 | U-1488 | Drug product | 2014-02-25 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8871809 | 2027-10-17 | U-1614 | 2014-11-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9066913 | 2027-10-17 | U-1488 | Drug product | 2015-06-30 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9101591 | 2027-10-17 | U-1488 | Drug product | 2015-08-11 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9132110 | 2027-10-17 | U-1488 | 2015-09-16 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9168304 | 2027-10-17 | Drug product | 2015-10-27 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9168305 | 2027-10-17 | U-1488 | 2015-10-27 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9220784 | 2027-10-17 | U-1488 | 2016-01-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9339551 | 2027-10-17 | U-1488 | 2016-06-16 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9339552 | 2027-10-17 | U-1488 | Drug product | 2016-06-16 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9539335 | 2027-10-17 | U-1614 | 2016-02-06 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8252838 | 2028-04-21 | U-1489 | Drug product | 2014-02-25 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8217078 | 2029-07-10 | U-1477 | 2014-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8618164 | 2029-07-10 | U-1477 | 2014-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8741956 | 2029-07-10 | U-1435 | 2014-06-05 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9370501 | 2029-07-10 | U-1614 | 2016-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9375412 | 2029-07-10 | U-1614 | 2016-07-26 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 9415029 | 2029-07-10 | U-1614 | 2016-09-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8546450 | 2030-08-09 | U-1435 | 2014-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204623-001 | 8546450 | 2030-08-09 | U-1436 | 2014-02-25 | c2088c7a36db… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium | DICLOFENAC SODIUM | NuCare Pharmaceuticals, LLC. | 26e44aa5-cfcd-f10b-e063-6394a90a4dcf | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| ZKBB ARTHRITIS PAIN RELIEF | DICLOFENAC SODIUM | Guchutang Biotechnology (Longyan) Co., Ltd | 5f5785c6-a762-34f5-e063-6294a90a95f6 | 2026-11-02 | Warnings | DICLOFENAC SODIUM |
| ZKBB PAIN RELIEF | DICLOFENAC SODIUM | Guchutang Biotechnology (Longyan) Co., Ltd | 5f392ab9-cd5c-2c09-e063-6294a90a4533 | 2026-11-01 | Warnings | DICLOFENAC SODIUM |
| arthritis pain reliever | DICLOFENAC SODIUM | H E B | e8fe4a89-586d-461c-b242-b68e38a508b4 | 2026-10-30 | Warnings | DICLOFENAC SODIUM |
| Diclofenac sodium | DICLOFENAC SODIUM | NuCare Pharmaceuticals, Inc. | 57c83158-f072-6fa2-e063-6394a90aee2c | 2026-10-29 | Warnings | DICLOFENAC SODIUM |
| arthritis pain relieving | DICLOFENAC SODIUM | Meijer Distribution Inc | d46a4841-2f86-4e0e-ac79-9b1444ed4f79 | 2026-10-28 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | Umedica Laboratories USA Inc. | 0e5c6669-390f-4c32-b9b8-13ed3c517462 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| arthritis pain reliever | DICLOFENAC SODIUM | HyVee Inc | bc74d53d-4142-4391-935b-61b7e353bd65 | 2026-10-20 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | YYBA CORP | 5dbffab4-d287-f0e3-e063-6394a90a311d | 2026-10-20 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | 0379c918-1717-40ab-81cc-268116950fd5 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Arthritis Pain Reliever | DICLOFENAC SODIUM | AmerisourceBergen (Good Neighbor Pharmacy) 46122 | 30e1f589-b322-48b7-9a97-502afe2a1baa | 2026-10-13 | Warnings | DICLOFENAC SODIUM |
| Diclofenac sodium | DICLOFENAC SODIUM | A-S Medication Solutions | 49ba1615-a719-4b04-b411-0c355635dce5 | 2026-10-10 | Warnings | DICLOFENAC SODIUM |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Redpharm Drug | 5cd83a0b-d2ef-7c21-e063-6294a90a63fd | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | bc99e6af-7050-4653-a681-5b252305a970 | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | Apotex Corp. | 9f416595-60b2-c921-5df4-a09d5f6abe71 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | d9698809-4887-4514-aa28-0066355ef908 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | NuCare Pharmaceuticals, Inc. | 5a852412-69af-6502-e063-6294a90a0748 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | Target Corporation | 55afc1c6-c1b7-a5ce-e063-6294a90ae45b | 2026-09-01 | Warnings | DICLOFENAC SODIUM |
| Diclofenac | DICLOFENAC SODIUM | YYBA CORP | 533653e8-93d5-9080-e063-6394a90a165b | 2026-09-01 | Warnings | DICLOFENAC SODIUM |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Proficient Rx LP | 67228d74-201a-460f-9e46-b8077289724a | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0574-0167 | DICLOFENAC SODIUM | diclofenac sodium | Padagis US LLC | NDA AUTHORIZED GENERIC | Current |
| 63629-9603 | DICLOFENAC SODIUM | diclofenac sodium | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | Current |
| 70518-2492 | Pennsaid | diclofenac sodium | REMEDYREPACK INC. | NDA | Current |
| 70518-2492 | Pennsaid | diclofenac sodium | REMEDYREPACK INC. | NDA | Current |
| 70518-2492 | Pennsaid | diclofenac sodium | REMEDYREPACK INC. | NDA | Current |
| 70518-2492 | Pennsaid | diclofenac sodium | REMEDYREPACK INC. | NDA | Current |
| 70518-2492 | Pennsaid | diclofenac sodium | REMEDYREPACK INC. | NDA | Current |
| 70748-335 | Diclofenac Sodium | Diclofenac Sodium | Lupin Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-040 | Pennsaid | diclofenac sodium | Horizon Pharma Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80396 | SUPPL | 2024-11-25 |
| 80395 | SUPPL | 2024-11-25 |
| 80314 | SUPPL | 2024-11-22 |
| 70017 | SUPPL | 2022-01-31 |
| 70004 | SUPPL | 2022-01-31 |
| 67745 | SUPPL | 2021-06-08 |
| 67744 | SUPPL | 2021-06-08 |
| 67734 | SUPPL | 2021-06-08 |
| 67362 | SUPPL | 2021-05-03 |
| 67361 | SUPPL | 2021-05-03 |
| 67287 | SUPPL | 2021-04-30 |
| 63564 | SUPPL | 2020-06-15 |
| 63486 | SUPPL | 2020-06-11 |
| 40400 | SUPPL | 2016-05-11 |
| 10366 | SUPPL | 2016-05-10 |
| 40399 | SUPPL | 2014-11-07 |
| 10365 | SUPPL | 2014-11-07 |
| 43469 | ORIG | 2014-10-07 |
| 24473 | ORIG | 2014-10-07 |
| 19576 | SUPPL | 2014-07-11 |
| 40398 | ORIG | 2014-01-17 |
| 10364 | ORIG | 2014-01-17 |